---
title: "Fennec Pharma (FENC.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/FENC.US/norm.md"
symbol: "FENC.US"
name: "Fennec Pharma"
parent: "https://longbridge.com/en/quote/FENC.US.md"
datetime: "2026-03-15T23:48:33.422Z"
locales:
  - [en](https://longbridge.com/en/quote/FENC.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/FENC.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/FENC.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/FENC.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/FENC.US/norm.md)


# Fennec Pharma (FENC.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.0229 | -0.1139 | -0.0422 | -0.0811 | -0.2100 |
| ROE | 42.69% | 188.98% | 79.31% | 143.80% | 702.82% |
| Revenue | 12.46M | 9.65M | 8.75M | 7.92M | 6.97M |
| Net income | -638000.00 | -3.15M | -1.17M | -1.99M | -5.74M |
| Operating income | -189000.00 | -2.73M | -808000.00 | -934000.00 | -5.20M |
| Gross margin | 94.70% | 89.98% | 95.74% | 91.56% | 80.54% |
| Net margin | -5.12% | -32.66% | -13.31% | -25.05% | -82.23% |
| Profit quality | -12.66% | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 49.26M | 44.88M | 46.40M | 44.95M | 58.92M |
| Leverage | -10.97 | -6.01 | -7.89 | -7.65 | -11.39 |
| BVPS | -0.1601 | -0.2691 | -0.2131 | -0.2133 | -0.1886 |
| Turnover | 0.7171 | 0.6165 | 0.5348 | 1.32 | 1.27 |
| Cash & STI | 21.95M | 18.70M | 22.68M | 26.63M | 40.32M |
| Inv & Rec | 2.48M | 2.20M | 1.40M | 1.06M | 1.13M |
| LT assets | - | - | - | - | - |
| Net debt | -2.57M | 659000.00 | -3.32M | -7.29M | -8.22M |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 1.49M | -3.69M | -4.32M | -1.47M | -2.21M |
| Investing CF | - | - | - | - | - |
| Financing CF | 1.75M | -284000.00 | 359000.00 | -12.21M | -528000.00 |
| Free CF | 1.50M | -1.93M | -1.04M | 210250.00 | -241250.00 |
| OCF coverage | - | - | - | -11.34% | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |

## Distribution Plan

### Dividend History

| Description | Record Date | Ex-Date | Payment Date |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
161.4633USD | 2002-11-14 | 2002-11-12 | 2002-11-28 |